Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
The SOC 1 and SOC 2 compliance audits and examinations were done by a leading independent, third-party audit firm in accordance with the standards established by the AICPA. This report attests to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results